The Pathology Shared Resource (PSR) provides four primary services for NCCC investigators: (1) it partners researchers with appropriate pathologists to provide specific expertise matched to the needs of the research project;(2) it coordinates the procurement, preservation, and distribution of human tissues and cells for funded and developmental NCCC basic and clinical research;(3) it performs histologic, immunohistologic, and molecular diagnostic procedures for NCCC researchers;and (4) it provides a GMP cell processing laboratory for the isolation/purification, manipulation, expansion and/or storage of cells derived from a patient's/subject's peripheral blood intended for autologous reinfusion. The PSR also works closely with the other NCCC Shared Resources to coordinate activities, share methodologies and other resources, and develop collaborative services where there is overlapping or complementary expertise. These functions are coordinated by the PSR Director and the PSR Supervisor. All procurement and histology requests by researchers are directed to the PSR Supervisor, who in concert with the other Department of Pathology members translates these requests into written operational protocols. These and the histology/immunohistology requests constitute the majority of requests made of the PSR at this time, and these operations are supervised by the Director with the assistance of the Research Histology Supervisor who oversees the technical aspects of histology and immunohistology services. Computer databases preserve information on clinical parameters and tissues for ready access by investigators who have institutionally-approved protocols. Requests for molecular diagnostic studies are reviewed by the Director, but the service itself is supervised by the Director of Molecular Services. Requests for leukocytes derived by apheresis for vaccine development are handled by the Cell Processing Laboratory and are coordinated by the director of that service.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-32
Application #
8015006
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-12-01
Budget End
2010-11-30
Support Year
32
Fiscal Year
2010
Total Cost
$103,994
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Smith, T Jarrod; Sondermann, Holger; O'Toole, George A (2018) Co-opting the Lap System of Pseudomonas fluorescens To Reversibly Customize Bacterial Cell Surfaces. ACS Synth Biol 7:2612-2617
Gorlova, Olga Y; Li, Yafang; Gorlov, Ivan et al. (2018) Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations. PLoS One 13:e0189498
Schmit, Stephanie L; Edlund, Christopher K; Schumacher, Fredrick R et al. (2018) Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst :
Cai, Yunliang; Wu, Shaoju; Zhao, Wei et al. (2018) Concussion classification via deep learning using whole-brain white matter fiber strains. PLoS One 13:e0197992
Trentham-Dietz, Amy; Ergun, Mehmet Ali; Alagoz, Oguzhan et al. (2018) Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening. Breast Cancer Res Treat 168:229-239
Moulton, Haley; Tosteson, Tor D; Zhao, Wenyan et al. (2018) Considering Spine Surgery: A Web-Based Calculator for Communicating Estimates of Personalized Treatment Outcomes. Spine (Phila Pa 1976) 43:1731-1738
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
Ferreiro-Iglesias, Aida; Lesseur, Corina; McKay, James et al. (2018) Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nat Commun 9:3927
Bronson, Mackenzie R; Kapadia, Nirav S; Austin, Andrea M et al. (2018) Leveraging Linkage of Cohort Studies With Administrative Claims Data to Identify Individuals With Cancer. Med Care 56:e83-e89
Gorlov, Ivan; Orlow, Irene; Ringelberg, Carol et al. (2018) Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics. Melanoma Res 28:380-389

Showing the most recent 10 out of 1911 publications